Back
Merck KGaA 10K Form
Buy
57
MKGAF
Merck KGaA
Last Price:
$147.47
Seasonality Move:
-3.71%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MKGAF News And Ratings
See the #1 stock for the next 7 days that we like better than MKGAF
MKGAF Financial Statistics
Sales & Book Value
| Annual Sales: | $22.9B |
|---|---|
| Cash Flow: | $604.6M |
| Price / Cash Flow: | 168.93 |
| Annual Sales: | $78.20 |
| Price / Book: | 1.84 |
Profitability
| EPS (TTM): | 7.54100 |
|---|---|
| Net Income (TTM): | $3.3B |
| Gross Margin: | $12.9B |
| Return on Equity: | 10.11% |
| Return on Assets: | 5.89% |
Merck KGaA Earnings Forecast
Key Merck KGaA Financial Ratios
-
The Gross Profit Margin over the past 23 years for MKGAF is 56.46%.
-
The Selling, General & Administrative Expenses for MKGAF have been equal to 27.92% of Gross Profit Margin.
-
The Research & Development expenses have been 10.72% of Revenue.
-
The Interest Expense is 7.57% of Operating Income.
-
The Net Earning history of MKGAF is 13.17% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 12 years.
Merck KGaA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | MKGAF |
| Website: | merckgroup.com |
Debt
| Debt-to-Equity Ratio: | 0.42 |
|---|---|
| Current Ratio: | 1.49 |
| Quick Ratio: | 0.76 |
Price-to-Earnings
| Trailing P/E Ratio: | 20.81 |
|---|---|
| Forward P/E Ratio: | 0 |
MKGAF Technical Analysis vs Fundamental Analysis
Buy
57
Merck KGaA (MKGAF)
is a Buy
Is Merck KGaA a Buy or a Sell?
-
Merck KGaA stock is rated a BuyThe current Merck KGaA [MKGAF] share price is $143.75. The Score for MKGAF is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.